DEFINITIVE HEALTHCARE CORP (DH)
US24477E1038 - Common Stock
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization
Definitive Healthcare Reports Financial Results for Third Quarter Fiscal Year 2024
Third quarter revenue exceeded guidance, and the Company announced a $100 million repurchase authorization...
Definitive Healthcare Announces Timing of Its Third Quarter 2024 Financial Results Conference Call and Webcast
Definitive Healthcare launches Monocl Conferences to improve conference planning and participation for biopharma and medtech organizations
Monocl Conferences equips life science organizations with an intuitive solution to enhance conference planning and KOL engagement
Definitive Healthcare launches Monocl Conferences to improve conference planning and participation for biopharma and medtech organizations
Monocl Conferences equips life science organizations with an intuitive solution to enhance conference planning and KOL engagement...
Definitive Healthcare launches predictive analytics solution that empowers healthcare organizations to prepare and plan for future market conditions
Market Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth opportunities
Definitive Healthcare launches predictive analytics solution that empowers healthcare organizations to prepare and plan for future market conditions
Market Forecast equips providers with three, five, and 10-year market trend projections to strengthen strategic planning around future demand and growth...
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Definitive Healthcare to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
FRAMINGHAM, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare...
The Law Offices of Frank R. Cruz Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion
Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer insights
Definitive Healthcare launches powerful consumer analytics and activation solution to more industries with Population Intelligence expansion
Population Intelligence empowers businesses to improve marketing campaigns and digital advertising performance with combined clinical and consumer...
DH Stock Earnings: Definitive Healthcare Meets EPS, Beats Revenue for Q2 2024
DH stock results show that Definitive Healthcare met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
DH Stock Earnings: Definitive Healthcare Meets EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Definitive Healthcare (NASDAQ:DH) just reported results for the second quarter ...
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2024
Second quarter revenue grew 5% year-over-year to $63.7 million
Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2024
Second quarter revenue grew 5% year-over-year to $63.7 million...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning!
Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast
Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence
DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices
Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence
DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices...
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today...
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
Empowering healthcare and life science organizations with faster insights through seamless data sharing
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
Empowering healthcare and life science organizations with faster insights through seamless data sharing...
Definitive Healthcare Publishes 2023 Sustainability Report
Second annual report showcases Definitive Healthcare’s continued successes related to culture, governance, and the environment
Definitive Healthcare Publishes 2023 Sustainability Report
Definitive Healthcare publishes 2023 Sustainability Report showcasing continued successes related to culture, governance, and the environment ...
Oversold Conditions For Definitive Healthcare (DH)
Definitive Healthcare to Present at the Stifel 2024 Cross Sector Insight Conference
Definitive Healthcare to Present at the Stifel 2024 Cross Sector Insight Conference
FRAMINGHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare...
Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company’s Growth
Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise
Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company’s Growth
Mr. Coop brings more than 30 years of Operations, Product and Revenue Expertise...
Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare...